Lima Sarah M, Nazareth Meaghan, Schmitt Karen M, Reyes Andria, Fleck Elaine, Schwartz Gary K, Terry Mary Beth, Hillyer Grace C
Mailman School of Public Health, Department of Epidemiology, Columbia University, New York, NY, USA.
Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY, USA.
J Community Genet. 2022 Dec;13(6):605-617. doi: 10.1007/s12687-022-00610-2. Epub 2022 Oct 13.
Risk-based genetic tests are often used to determine cancer risk, when to initiate screening, and frequency of screening, but rely on interest in genetic testing. We examined overall interest in genetic testing for cancer risk assessment and willingness to change behavior, and whether these are affected by demographic or socioeconomic factors.We conducted a community needs health survey in 2019 among primary care and cancer patients, family members and community members in New York City. We used univariable analysis and relative risk regression to examine interest in genetic cancer risk testing and willingness to modify lifestyle behaviors in response to an informative genetic test.Of the 1225 participants, 74.0% (n = 906) expressed interest in having a genetic test to assess cancer risk. Interest in genetic testing was high across all demographic and socioeconomic groups; reported interest in genetic testing by group ranged from 65.0 (participants aged 65 years and older) to 83.6% (participants below federal poverty level). Among the 906 participants that reported interest in genetic testing, 79.6% were willing to change eating habits, 66.5% to change exercise habits, and 49.5% to lose weight in response to an informative genetic test result.Our study reveals that interest in genetic testing for cancer risk is high among patients and community members and is high across demographic and socioeconomic groups, as is the reported willingness to change behavior. Based on these results, we recommend that population-based genetic testing may result in greater reduction cancer risk, particularly among minoritized groups.
基于风险的基因检测常用于确定癌症风险、何时开始筛查以及筛查频率,但这依赖于对基因检测的兴趣。我们研究了对用于癌症风险评估的基因检测的总体兴趣以及改变行为的意愿,以及这些是否受到人口统计学或社会经济因素的影响。2019年,我们在纽约市对初级保健患者、癌症患者、家庭成员和社区成员进行了一项社区需求健康调查。我们使用单变量分析和相对风险回归来研究对遗传性癌症风险检测的兴趣以及根据信息丰富的基因检测结果改变生活方式行为的意愿。在1225名参与者中,74.0%(n = 906)表示有兴趣进行基因检测以评估癌症风险。所有人口统计学和社会经济群体对基因检测的兴趣都很高;按群体报告的对基因检测的兴趣范围从65.0%(65岁及以上的参与者)到83.6%(低于联邦贫困线的参与者)。在报告对基因检测感兴趣的906名参与者中,79.6%愿意根据信息丰富的基因检测结果改变饮食习惯,66.5%愿意改变运动习惯,49.5%愿意减肥。我们的研究表明,患者和社区成员对用于癌症风险的基因检测兴趣很高,并且在人口统计学和社会经济群体中都很高,报告的改变行为的意愿也是如此。基于这些结果,我们建议基于人群的基因检测可能会更大程度地降低癌症风险,特别是在少数群体中。